logo
Sign in

TALIGEN THERAPEUTICS INC

CAMBRIDGE, MA · Still private

Claim this profile

Follows are private to you and power your alerts

Updated

Headquarters
CAMBRIDGE, MA
Total capital
$37.1M
Federal grants
$1M
5 awards · 2005–2006
Private capital raised
$36M
0 Form D · last
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

20052006FEDERAL ↑EQUITY ↓Cumulative $1M$97K$288K$280K$179K$175K
20052006FEDERAL ↑EQUITY ↓Cumulative $1M$288K$280K$175K

Latest events

  • Federal grantHealth and Human S · Phase I · The Use of Complement Inhibitors as therapeutic agents in AMD$175K
  • Federal grantHealth and Human S · Phase I · Targeted Complement Inhibitors as Therapeutic Agents$179K
  • Federal grantHealth and Human S · Phase I · Monoclonal Antibody to Factor B as Therapeutic in Asthma$280K
  • Federal grantHealth and Human S · Phase I · Monoclonal antibody to Factor B as a Therapeutic in Asthma$288K
  • Federal grantHealth and Human S · Phase I · A Novel Complement Inhibitor for Rheumatoid Arthritis$97K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Abbie CelnikerExecutive Officer, DirectorNamed in SEC Form D filings
  • Ed HurwitzDirectorNamed in SEC Form D filings
  • John C MaraganoreDirectorNamed in SEC Form D filings
  • Nicholas GalakatosDirectorNamed in SEC Form D filings
  • Timothy C MillsDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 3
  • PendingTreatment Of Paroxysmal Nocturnal Hemoglobinuria, Hemolytic Anemias And Disease States Involving Intravascular And Extravascular HemolysisUSPTOApplication PCTUS2010055745
  • PendingLigand-specific Non-antibody Compounds That Inhibit CR2 Activation And Methods Of Use ThereofUSPTOApplication PCTUS2009057580
  • PendingHumaneered Anti-factor B AntibodyUSPTOApplication PCTUS2008003381

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .